Skip to main content
logo
Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.2000
-0.0300 (-13.04%)
Oct 9, 2026, 5:39 PM CET

Celyad Oncology Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.010.020.190.1--
Revenue Growth
-66.67%-88.71%82.35%---
Gross Profit
0.240.010.170.03--
Operating Income
0.93-1.53-5.87-9.54-25.45-27.24
Net Income
3.30.83-5.82-8.45-40.94-26.51
Earnings Per Share
0.070.02-0.14-0.33-1.81-1.70
EPS Growth
282.21%-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.121.714.2712.4530.02
Total Debt
--0.911.060.262.63
Net Cash (Debt)
0.121.713.35.9512.1927.39
Net Cash Growth
-92.92%-48.16%-44.59%-51.22%-55.49%101.43%
Net Cash Per Share
0.000.040.080.230.541.76

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.11-6.9-5.68-15.2-28.01-26.64
Capital Expenditures
----0.9-0.12-0.33
Free Cash Flow
-5.11-6.9-5.68-16.1-28.13-26.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
3357.14%61.91%93.55%32.35%--
Operating Margin
13300.00%-7261.90%-3155.38%-9356.86%--
Pretax Margin
47071.43%3952.38%-3131.18%-8344.12%--
Profit Margin
47071.43%3952.38%-3131.18%-8282.35%--
FCF Margin
-72957.14%-32857.14%-3053.76%-15785.29%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.919.17----
PS Ratio
1278.91362.36158.59158.40--